BRAHMS KRYPTOR Procalcitonin
Device
Brahms GmbH
Total Payments
$450,813
Transactions
7
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $250,813 | 4 | 0 |
| 2019 | $200,000 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $450,813 | 7 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PROcalcitonin impact on antibiotic reduction, adverSe events and AVoidable healthcarE costs (ProSAVE) | Brahms GmbH | $200,000 | 0 |
| PROcalcitonin impact on antibiotic reduction, adverSe events and AVoidable healthcarE costs (ProSAVE): A RCT | Brahms GmbH | $200,000 | 0 |
| COVID-19 Study | Brahms GmbH | $50,813 | 0 |
Top Doctors Receiving Payments for BRAHMS KRYPTOR Procalcitonin
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $450,813 | 7 |
Ad
Manufacturing Companies
- Brahms GmbH $450,813
Product Information
- Type Device
- Total Payments $450,813
- Total Doctors 0
- Transactions 7
About BRAHMS KRYPTOR Procalcitonin
BRAHMS KRYPTOR Procalcitonin is a device associated with $450,813 in payments to 0 healthcare providers, recorded across 7 transactions in the CMS Open Payments database. The primary manufacturer is Brahms GmbH.
Payment data is available from 2019 to 2020. In 2020, $250,813 was paid across 4 transactions to 0 doctors.
The most common payment nature for BRAHMS KRYPTOR Procalcitonin is "Unspecified" ($450,813, 100.0% of total).
BRAHMS KRYPTOR Procalcitonin is associated with 3 research studies, including "PROcalcitonin impact on antibiotic reduction, adverSe events and AVoidable healthcarE costs (ProSAVE)" ($200,000).